Andrew T Miller

Title: Andrew T Miller: Innovator in Pharmaceutical Compositions

Introduction

Andrew T Miller is a notable inventor based in San Diego, CA, with a focus on pharmaceutical innovations. He holds two patents that contribute significantly to the field of cancer treatment. His work emphasizes the development of compounds and compositions aimed at addressing solid tumors and respiratory conditions.

Latest Patents

Miller's latest patents include "Compounds and compositions for treating solid tumors by intratumoral administration." This invention encompasses pharmaceutical compositions that feature a TLR7 agonist, aluminum-containing particles, and one or more pharmaceutically acceptable excipients. The patent outlines the use of these compositions in treating solid tumors, either independently or in conjunction with additional pharmaceutical formulations. Another significant patent is for "Pyrimidine compounds containing acidic groups." This disclosure pertains to a class of pyrimidine derivatives with immunomodulating properties that act via TLR7, proving useful in treating lung cancer and other respiratory ailments.

Career Highlights

Throughout his career, Andrew T Miller has worked with prominent companies such as Apros Therapeutics, Inc. and Novartis AG. His contributions to these organizations have been instrumental in advancing pharmaceutical research and development.

Collaborations

Miller has collaborated with notable colleagues, including Tom Yao-Hsiang Wu and Michael P Cooke. These partnerships have fostered innovation and enhanced the impact of his work in the pharmaceutical industry.

Conclusion

Andrew T Miller's contributions to pharmaceutical compositions and cancer treatment exemplify his dedication to innovation in the field. His patents reflect a commitment to improving patient outcomes through advanced therapeutic solutions.